Last $0.03 USD
Change Today +0.005 / 25.00%
Volume 35.0K
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

lescarden inc (LCAR) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.03
Day Low
$0.02
52 Week High
01/17/14 - $0.09
52 Week Low
08/4/14 - $0.02
Market Cap
1.6M
Average Volume 10 Days
8.4K
EPS TTM
$-0.0012
Shares Outstanding
63.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LESCARDEN INC (LCAR)

Related News

No related news articles were found.

lescarden inc (LCAR) Related Businessweek News

No Related Businessweek News Found

lescarden inc (LCAR) Details

Lescarden Inc. researches and develops proprietary biologic materials focusing on wound healing, clinical skin care, osteoarthritis, and cancer applications. The company offers Catrix Wound Dressing for the management of chronic lesions and burns, as well as non-healing wounds, such as decubitus ulcers, venous stasis ulcers, and diabetic ulcers. It also provides a line of Catrix-based skin care products for plastic surgery, dermatology, and medical spa markets. In addition, the company offers nutritional supplements, including Bio-Cartilage and Poly-NAG, a glucosamine polymer. Lescarden Inc. sells and licenses its products and technologies in Canada, Europe, and South Korea. The company was founded in 1960 and is based in New York, New York.

1 Employees
Last Reported Date: 08/29/14
Founded in 1960

lescarden inc (LCAR) Top Compensated Officers

Chief Executive Officer, President, Chief Fin...
Total Annual Compensation: $68.8K
Compensation as of Fiscal Year 2014.

lescarden inc (LCAR) Key Developments

Lescarden Inc. Auditor Raises 'Going Concern' Doubt

Lescarden Inc. filed its 10-K on Aug 29, 2014 for the period ending May 31, 2014. In this report its auditor, Cowan, Gunteski & Co., P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Lescarden Inc. Reports Earnings Results for the Full Year Ended May 31, 2013

Lescarden Inc. reported earnings results for the full year ended May 31, 2013. The company reported net loss for the year ended May 31, 2013 was $257,427, or $0.01 loss per share, compared to a net loss of $185,469, or $0 per share, for the year ended May 31, 2012. Total revenues for the year ended May 31, 2013 were $403,120, compared to $418,708, for the year ended May 31, 2012. Operating loss for the year ended May 31, 2013 was $302,132, compared to an operating loss of $185,494, for the year ended May 31, 2012. Other income for the year ended May 31, 2013 was $44,705, compared to $25 for the year ended May 31, 2012.

Lescarden Inc. Auditor Raises 'Going Concern' Doubt

Lescarden Inc. filed its 10-K on Aug 29, 2013 for the period ending May 31, 2013. In this report its auditor, Cowan, Gunteski & Co., P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LCAR:US $0.03 USD +0.005

LCAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LCAR.
View Industry Companies
 

Industry Analysis

LCAR

Industry Average

Valuation LCAR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 16.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LESCARDEN INC, please visit www.lescarden.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.